Bukwang Pharmaceutical Co., Ltd. (KRX:003000)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,030.00
+20.00 (0.50%)
At close: Jun 5, 2025, 3:30 PM KST

Bukwang Pharmaceutical Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Cash & Equivalents
87,81390,091151,22785,51782,77779,291
Upgrade
Short-Term Investments
45,00040,000--1,50010,300
Upgrade
Cash & Short-Term Investments
132,813130,091151,22785,51784,27789,591
Upgrade
Cash Growth
-18.25%-13.98%76.84%1.47%-5.93%138.37%
Upgrade
Accounts Receivable
23,45423,55935,72987,95090,428103,675
Upgrade
Other Receivables
1,571994.311,647360.042,413309.45
Upgrade
Receivables
25,02524,55337,37688,31092,842103,985
Upgrade
Inventory
41,66741,66756,83238,60739,29451,375
Upgrade
Prepaid Expenses
418.42398.29166.97173.46205.7216.08
Upgrade
Other Current Assets
6,5417,0308,5766,1343,4763,043
Upgrade
Total Current Assets
206,464203,739254,179218,741220,095248,209
Upgrade
Property, Plant & Equipment
142,813141,481122,789123,960124,531106,298
Upgrade
Long-Term Investments
12,98716,77531,62635,13236,96334,189
Upgrade
Goodwill
406.62406.62878.73834.51828.7827.05
Upgrade
Other Intangible Assets
5,9835,8689,1776,1576,1516,172
Upgrade
Long-Term Deferred Tax Assets
----3.637.27
Upgrade
Other Long-Term Assets
3,9904,91010,36816,1058,8435,266
Upgrade
Total Assets
372,643373,180429,017400,929397,417400,969
Upgrade
Accounts Payable
6,3615,0622,36816,5307,42110,157
Upgrade
Accrued Expenses
-1,9072,9781,7551,7762,055
Upgrade
Short-Term Debt
-----20,000
Upgrade
Current Portion of Leases
380.87130.19217.6242.91444.17407.98
Upgrade
Current Income Taxes Payable
98.04-357.474,3123,9967,291
Upgrade
Other Current Liabilities
28,40228,29991,62221,76423,35821,293
Upgrade
Total Current Liabilities
35,24335,39897,54444,60336,99561,204
Upgrade
Long-Term Debt
79,13579,02478,525---
Upgrade
Long-Term Leases
642.7269.91644.17687.881,1141,139
Upgrade
Long-Term Deferred Tax Liabilities
13,45513,91710,06811,01111,2174,984
Upgrade
Other Long-Term Liabilities
425.12425.127,97172,78068,03062,450
Upgrade
Total Liabilities
128,901129,035194,752129,082117,356129,778
Upgrade
Common Stock
36,40236,40236,40236,40236,40233,289
Upgrade
Additional Paid-In Capital
12,45212,4524,8086,8007,3577,071
Upgrade
Retained Earnings
166,901166,822225,783258,585264,703273,253
Upgrade
Treasury Stock
---50,784-50,784-50,784-50,268
Upgrade
Comprehensive Income & Other
27,56128,00010,10312,21511,930-4,846
Upgrade
Total Common Equity
243,315243,676226,311263,217269,608258,499
Upgrade
Minority Interest
427.44469.857,9538,63010,45312,692
Upgrade
Shareholders' Equity
243,742244,146234,265271,847280,061271,191
Upgrade
Total Liabilities & Equity
372,643373,180429,017400,929397,417400,969
Upgrade
Total Debt
80,15979,42479,387930.791,55821,547
Upgrade
Net Cash (Debt)
52,65550,66771,84084,58682,71968,044
Upgrade
Net Cash Growth
-36.48%-29.47%-15.07%2.26%21.57%91.64%
Upgrade
Net Cash Per Share
766.79740.151049.461235.651208.27991.46
Upgrade
Filing Date Shares Outstanding
68.4568.4568.4568.4568.4562.25
Upgrade
Total Common Shares Outstanding
68.4568.4568.4568.4568.4568.48
Upgrade
Working Capital
171,222168,341156,634174,138183,101187,005
Upgrade
Book Value Per Share
3554.393559.673306.003845.133938.483775.04
Upgrade
Tangible Book Value
236,926237,401216,255256,226262,628251,500
Upgrade
Tangible Book Value Per Share
3461.063468.003159.103743.013836.523672.83
Upgrade
Land
112,939113,31492,87592,87592,87571,163
Upgrade
Buildings
51,38351,49951,45050,60250,60250,577
Upgrade
Machinery
49,81649,27648,40648,08046,34346,030
Upgrade
Construction In Progress
189.28311.17-76.21-52.2
Upgrade
Updated Mar 18, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.